These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2882409)
21. Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists. Johnson RA; Shoshani I J Biol Chem; 1990 Nov; 265(31):19035-9. PubMed ID: 2121733 [TBL] [Abstract][Full Text] [Related]
22. The metabolism of exogenously supplied nucleotides by Escherichia coli. LICHTENSTEIN J; BARNER HD; COHEN SS J Biol Chem; 1960 Feb; 235():457-65. PubMed ID: 14416749 [No Abstract] [Full Text] [Related]
23. ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN. MOLNAR DM; ALTENBERN RA Proc Soc Exp Biol Med; 1963 Nov; 114():294-7. PubMed ID: 14101169 [No Abstract] [Full Text] [Related]
24. Purification of the third factor of anthrax toxin. SMITH H; STANLEY JL J Gen Microbiol; 1962 Nov; 29():517-21. PubMed ID: 13989434 [No Abstract] [Full Text] [Related]
25. The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity. STANLEY JL; SMITH H J Gen Microbiol; 1963 May; 31():329-37. PubMed ID: 13983400 [No Abstract] [Full Text] [Related]
26. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures. PUZISS M; MANNING LC; LYNCH JW; BARCLAYE ; ABELOW I; WRIGHT GG Appl Microbiol; 1963 Jul; 11(4):330-4. PubMed ID: 13972634 [TBL] [Abstract][Full Text] [Related]
27. Purification of factor I and recognition of a third factor of the anthrax toxin. STANLEY JL; SMITH H J Gen Microbiol; 1961 Sep; 26():49-63. PubMed ID: 13916257 [No Abstract] [Full Text] [Related]
28. Production of toxin in vitro by Bacillus anthracis and its spearation into two components. THORNE CB; MOLNAR DM; STRANGE RE J Bacteriol; 1960 Mar; 79(3):450-5. PubMed ID: 13838209 [No Abstract] [Full Text] [Related]
29. Purification of factors I and II of the anthrax toxin produced in vivo. STANLEY JL; SARGEANT K; SMITH H J Gen Microbiol; 1960 Feb; 22():206-18. PubMed ID: 13833788 [No Abstract] [Full Text] [Related]
30. The chemical basis of the virulence of Bacillus anthracis. VII. Two components of the anthrax toxin: their relationship to known immunising aggressins. SMITH H; TEMPEST DW; STANLEY JL; HARRIS-SMITH PW; GALLOP RC Br J Exp Pathol; 1956 Jun; 37(3):263-71. PubMed ID: 13342351 [No Abstract] [Full Text] [Related]
31. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo. SMITH H; KEPPIE J; STANLEY JL Br J Exp Pathol; 1955 Oct; 36(5):460-72. PubMed ID: 13269658 [No Abstract] [Full Text] [Related]
32. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Katada T; Ui M Proc Natl Acad Sci U S A; 1982 May; 79(10):3129-33. PubMed ID: 6954463 [TBL] [Abstract][Full Text] [Related]
33. Ca2+ regulation of cyclic nucleotide metabolism. Keller CH; LaPorte DC; Toscano WA; Storm DR; Westcott KR Ann N Y Acad Sci; 1980; 356():205-19. PubMed ID: 6940496 [No Abstract] [Full Text] [Related]
34. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Leppla SH Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():189-98. PubMed ID: 6328915 [TBL] [Abstract][Full Text] [Related]